TMEM132D and ovarian neoplasm: By employing a fluorescent version of ADDER Differential Display, we have recently reported the identification of 128 genes overexpressed in early stage ovarian tumors enriched with CD8+ T-lymphocytes (TIL+ tumors) [19]. GPC6 and TMEM132D, encoding for the heparan sulfate proteoglycan Glypican-6 and the transmembrane protein 132D, respectively, were included in the identified genes (Figures 1(a) and 2(a), resp).